These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19615288)

  • 41. Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601.
    Sugawara S; Maemondo M; Tachihara M; Inoue A; Ishimoto O; Sakakibara T; Usui K; Watanabe H; Matsubara N; Watanabe K; Kanazawa K; Ishida T; Saijo Y; Nukiwa T;
    Lung Cancer; 2013 Jul; 81(1):91-6. PubMed ID: 23643176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma.
    Chen YM; Yu CJ; Yang CH; Perng RP; Tsai CM; Shih JF; Cheng AL; Lefresne F; Barbier M; Pouget JC; Yang PC
    Lung Cancer; 2007 Apr; 56(1):89-95. PubMed ID: 17208330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.
    Juan O; Sánchez-Hernández A; Vázquez S; Casal J; Firvida JL; Aparisi F; Muñoz J; García-Sánchez J; Gironés R; Lázaro M; Giner V
    Anticancer Res; 2014 Apr; 34(4):1959-66. PubMed ID: 24692732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer.
    Farhat FS; Ghosn MG; Kattan JG
    Cancer Chemother Pharmacol; 2015 Aug; 76(2):235-42. PubMed ID: 26024554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study.
    Beckmann G; Fietkau R; Huber RM; Kleine P; Schmidt M; Semrau S; Aubert D; Fittipaldo A; Flentje M
    Onkologie; 2006 Apr; 29(4):137-42. PubMed ID: 16601369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: a phase II study.
    Martoni AA; Melotti B; Sperandi F; Giaquinta S; Piana E; Pavesi L; Da Prada G; Lelli G
    Lung Cancer; 2008 Jun; 60(3):387-92. PubMed ID: 18160123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer.
    Flentje M; Huber RM; Engel-Riedel W; Andreas S; Kollmeier J; Staar S; Dickgreber N; Vaissiere N; De Almeida C; Edlich B; Fietkau R
    Strahlenther Onkol; 2016 Apr; 192(4):216-22. PubMed ID: 26809652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.
    Shukuya T; Takahashi T; Harada H; Akamatsu H; Sakaguchi C; Imai H; Ono A; Nakamura Y; Tsuya A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi K; Yamamoto N
    Anticancer Res; 2012 Feb; 32(2):675-80. PubMed ID: 22287762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.
    Khuri FR; Rigas JR; Figlin RA; Gralla RJ; Shin DM; Munden R; Fox N; Huyghe MR; Kean Y; Reich SD; Hong WK
    J Clin Oncol; 2001 May; 19(10):2626-37. PubMed ID: 11352954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
    Zhang P; Feng FY; Wu LY; Hu Y; Liu JW; Gao YJ; Guan XQ; Nan KJ; Suo AL; Wang XW; Zhang MH; Zhang WD; Li CW; Zhang Y; Zhao JB
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):230-4. PubMed ID: 16875614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gefitinib (IRESSA) with vinorelbine or vinorelbine/cisplatin for chemotherapy-naive non-small cell lung cancer patients.
    Pujol JL; Viens P; Rebattu P; Laurie SA; Feld R; Deneulin A; Fandi A
    J Thorac Oncol; 2006 Jun; 1(5):417-24. PubMed ID: 17409893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Vinorelbine plus oxaliplatin versus vinorelbine plus cisplatin for advanced non-small cell lung cancer: a systematic review].
    Liu X; Ma L; Yang K; Tian J
    Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):112-7. PubMed ID: 20673502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
    Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A randomized trial of docetaxol plus cisplatin versus gemzar plus cisplatin in treating advanced non-small cell lung cancer].
    Gao Y; Shi ZQ; Cao CW; Zhu CL; Guo J
    Ai Zheng; 2005 Aug; 24(8):985-9. PubMed ID: 16086878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effect of thalidomide in preventing delayed nausea and vomiting induced by GP regimen of chemotherapy for non-small cell lung cancer].
    Yu YL; Zhu ZT; Li JP; Ha MW; Liu XM; Wu Q; Xing YD
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):937-40. PubMed ID: 20193338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Enhancing effect of compound Kusheng injection in combination with chemotherapy for patients with advanced non-small cell lung cancer].
    Fan CX; Lin CL; Liang L; Zhao YY; Liu J; Cui J; Yang QM; Wang YL; Zhang AR
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):294-7. PubMed ID: 20510083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival.
    Guo L; Bai SP; Zhao L; Wang XH
    Med Oncol; 2012 Sep; 29(3):1656-62. PubMed ID: 21928106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy and safety of chemotherapy combined with interstitial (125)I seed implantation brachytherapy in unresectable stage IIIa/IIIb non-small cell lung cancer].
    Yang SF; Fan XW; Zhang GQ; Shan L
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):626-9. PubMed ID: 21122419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cisplatin-vinorelbine chemotherapy in non-small cell lung cancer is safe and well tolerated: results of a retrospective Hungarian clinical data analysis.
    Szilasi M; Müller V; Juhász E; Magyar P; Budai M; Tamási L
    Expert Opin Drug Saf; 2009 Jan; 8(1):9-14. PubMed ID: 19236214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.